Drug Search Results
More Filters [+]

PRIM-DJ2727

Alternative Names: prim-dj2727, primdj2727, prim dj2727
Latest Update: 2024-05-14
Latest Update Note: Clinical Trial Update

Product Description

For Parkinson's Disease (PD)

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: University of Texas Health Science Center, Houston
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for PRIM-DJ2727

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Clostridium Infections|Parkinson's Disease|Liver Diseases, Alcoholic|Non-alcoholic Fatty Liver Disease|Colitis, Ulcerative|Inflammation|Fatty Liver, Alcoholic

Phase 1: Hepatitis, Alcoholic|HIV Infections|Parkinson's Disease|Hepatitis A|Colitis, Ulcerative

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

HSC-MS-23-0016

P1

Recruiting

Colitis, Ulcerative

2026-12-15

HSC-MS-20-0316

P2

Recruiting

Colitis, Ulcerative|Inflammation

2025-12-31

HSC-SPH-19-1126

P2

Withdrawn

Non-alcoholic Fatty Liver Disease|Liver Diseases, Alcoholic|Fatty Liver, Alcoholic

2024-12-01

H-43752

P1

Recruiting

Hepatitis, Alcoholic|Hepatitis A

2024-07-31

Recent News Events